Alto Neuroscience, Inc. (ANRO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$68.11M
Year ended 2024-12-31
2023-12-31: -$37.44M2024-12-31: -$68.11M-$68.11M
2023-12-31 EBITDA (USD) 2024-12-31
Period endedEBITDAChange YoYSource filing
2024-12-31-$68.11Mn/m2026-03-16, From 2024-01-01
2023-12-31-$37.44Mn/a2025-03-20, From 2023-01-01